国产自慰在线观看,无码乱人伦一区二区亚洲第一,找av综合福利,人人草人人
join us
CN
Home page
About Us
Profile
Affiliates/Subsidiaries
Development History
Quality Management
Contact Us
Legal Statement
Adverse Reaction Report
Science and Technology
R&D platform
R&D pipeline
Therapeutic Field
International Business
APIs
Finished Products
Medical device
Download product list
Contact
News Center
News & Trends
Public information
News & Trends
14
2025-02
SAL0140 Clinical Trial Application Accepted by NMPA, Potential Breakthrough in Hypertension Treatment
20
2025-01
Announcement of the Positive Interim Data from the Phase 2 Trial of JK07 in Heart Failure
28
2024-11
Salubris’innovative drugs Xinliting and FoLitan ? have been included in China's national reimbursement drug list
27
2024-08
Salubris obtaining the exclusive right of base editing drug YOLT-101
05
2024-08
The innovative anti-tumor drug JK06 was approved for overseas clinical trial
01
2024-08
Enarodustat’s new indication approved for clinical trial
目前在第
1
頁(yè),
共有
10
頁(yè),
共有
60
條記錄
第一頁(yè)
上一頁(yè)
1
2
3
4
5
下一頁(yè)
最后一頁(yè)
跳轉(zhuǎn)到
頁(yè)